Related Experiment Video

Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Medical consequences of childhood obesity: a Hong Kong perspective

Alice Pik Shan Kong1, Chun Chung Chow

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China. alicekong@cuhk.edu.hk

Research in Sports Medicine (Print)
|April 15, 2010
PubMed

Insights

Childhood obesity is a growing global epidemic. This review examines its medical consequences in Hong Kong youth, including cardiovascular risks and nonalcoholic fatty liver disease (NAFLD).

Area of Science:

  • Pediatrics
  • Public Health
  • Cardiology

Background:

  • Childhood obesity represents a significant global health challenge.
  • Obesity in youth is linked to serious medical conditions and cardiovascular risk factors.
  • Understanding local epidemiology is crucial for targeted interventions.

Purpose of the Study:

  • To review the epidemiology of childhood obesity in Hong Kong Chinese children and adolescents.
  • To explore the medical consequences associated with youth obesity in this population.
  • To identify research directions for understanding the etiology of these associations.

Main Methods:

  • Literature review of local clinical evidence.
  • Analysis of epidemiological data on childhood obesity in Hong Kong.
  • Synthesis of findings on medical consequences and etiological factors.

Main Results:

  • Childhood obesity is associated with impaired glucose tolerance, hypertension, and atherogenic dyslipidemia.
  • Comorbidities such as nonalcoholic fatty liver disease (NAFLD), sleep apnea, and early atherosclerosis are prevalent.
  • Evidence highlights specific patterns within the Hong Kong Chinese youth population.

Conclusions:

  • Childhood obesity in Hong Kong youth presents significant medical challenges.
  • Further research is needed to elucidate the etiological factors driving these associations.
  • Targeted public health strategies are essential to combat this epidemic.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...